Question 1

What specific benefits might AXA1665 offer compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy clinical trial (NCT04816916). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of AXA1665?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy clinical trial (NCT04816916). Contact the study team or your healthcare provider for specific answers.

Question 3

How often would I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy clinical trial (NCT04816916). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects while participating in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy clinical trial (NCT04816916). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy clinical trial (NCT04816916). Contact the study team or your healthcare provider for specific answers.

Question 6

Can you explain the difference between AXA1665 and the placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy clinical trial (NCT04816916). Contact the study team or your healthcare provider for specific answers.

What this study is about